Express News | WHO's Tedros Adhanom Ghebreyesus Posts On X "In #DRC Alone, More Than 4500 Cases of #mpox and Almost 300 Deaths Have Been Reported This Year. That Is Triple the Number Reported at This Time Last Year. The Recent Surge in Cases and Deaths Among Children Is
Moomoo 24/7Apr 11 10:09 ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersProtara Therapeutics (NASDAQ:TARA) stock increased by 40.3% to $5.64 during Friday's pre-market session. The market value of their outstanding shares is at $64.4 million. Candel Therapeutics (N
BenzingaApr 5 08:09 ET
GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine
GeoVax Labs, Inc. (Nasdaq: GOVX) today announced that its Chief Scientific Officer, Mark Newman, PhD, presented data on GEO-CM04S1, the Company's next-generation Covid-19 vaccine candidate, during the 24th Annual World Vaccine Congress in Washington, DC.
GlobeNewswireApr 4 12:30 ET
GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress
ATLANTA, GA, March 28, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious di
GlobeNewswireMar 28 09:00 ET
GeoVax to Present at the 36th Annual Roth Conference
ATLANTA, GA, March 12, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious d
GlobeNewswireMar 12 09:00 ET
Noble Financial Reaffirms Their Buy Rating on GeoVax Labs (GOVX)
TipRanksMar 7 08:15 ET
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production Being Developed for GeoVax MVA-Based Vaccines ATLANTA, GA, March 06, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasda
GlobeNewswireMar 6 09:00 ET
Express News | GeoVax Labs Inc Files For Mixed Shelf Of Up To $100M
Moomoo 24/7Mar 1 16:16 ET
Earnings Call Summary | GeoVax Labs(GOVX.US) Q4 2023 Earnings Conference
The following is a summary of the GeoVax Labs, Inc. (GOVX) Q4 2023 Earnings Call Transcript:Financial Performance:GeoVax Labs reported a net loss for 2023 of $265 million, or $14.29 per share, driven
moomoo AIMar 1 11:19 ET · Conference Call
Analysts Offer Insights on Healthcare Companies: GeoVax Labs (GOVX), Madrigal Pharmaceuticals (MDGL) and Spyre Therapeutics (SYRE)
TipRanksMar 1 08:10 ET
GeoVax GAAP EPS of -$14.29 Beats by $0.26
Seeking AlphaFeb 29 18:14 ET
Geovax Labs: Q4 Earnings Insights
Geovax Labs (NASDAQ:GOVX) reported its Q4 earnings results on Thursday, February 29, 2024 at 04:00 PM.Here's what investors need to know about the announcement.EarningsGeovax Labs missed estimated ear
BenzingaFeb 29 16:10 ET
Express News | Geovax Labs Q4 2023 GAAP EPS $(3.940) Misses $(2.780) Estimate
Moomoo 24/7Feb 29 16:08 ET
GeoVax Labs Anticipates Reporting Additional Results From the Gedeptin Phase 1/2 Clinical Trial in 1H 2024>GOVX
GeoVax Labs Anticipates Reporting Additional Results From the Gedeptin Phase 1/2 Clinical Trial in 1H 2024>GOVX
Dow JonesFeb 29 16:03 ET
Earnings Scheduled For February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. • NB Bancorp (NASDAQ:NBBK) is likely to report ear
BenzingaFeb 29 05:15 ET
Notable Earnings After Thursday's Close
Seeking AlphaFeb 28 17:35 ET
Earnings Outlook For Geovax Labs
Geovax Labs (NASDAQ:GOVX) is set to give its latest quarterly earnings report on Thursday, 2024-02-29. Here's what investors need to know before the announcement.Analysts estimate that Geovax Labs wil
BenzingaFeb 28 14:02 ET
InMed Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
The Dow Jones index closed higher by over 450 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders
BenzingaFeb 23 07:34 ET
GeoVax Labs(GOVX.US) Officer Buys US$19,781.16 in Common Stocks
$GeoVax Labs(GOVX.US)$ Officer DODD DAVID A purchased 8,729 shares of Common Stocks on Feb 21, 22, 2024 at an average price of $2.2661 for a total value of $19,781.16.Source: Announcement What is stat
moomoo NewsFeb 22 17:21 ET
Press Release: GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024
GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024 GeoVax to Host Conference Call at 4:30 PM ET ATLANTA, GA, Feb. 22, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire
Dow JonesFeb 22 09:00 ET
No Data
No Data